Advanced Search (OLGA)

Gene: RBAK (RB associated KRAB zinc finger) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

RBAK

Name:

RB associated KRAB zinc finger

RGD ID:

1602691

HGNC Page

HGNC:17680

Description:

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in nucleoplasm.

Type:

protein-coding

RefSeq Status:

REVIEWED

Previously known as:

hRBaK; RB-associated KRAB repressor; RB-associated KRAB zinc finger protein; zinc finger protein 769; ZNF769

RGD Orthologs

Alliance Orthologs

More Info

more info ...

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	7	5,045,860 - 5,069,487 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	7	5,045,821 - 5,069,487 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	7	5,085,491 - 5,109,118 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	7	5,052,079 - 5,075,645 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Celera	7	5,044,901 - 5,068,467 (+)	NCBI		Celera
Cytogenetic Map	7	p22.1	NCBI
HuRef	7	5,000,481 - 5,024,148 (+)	NCBI		HuRef
CHM1_1	7	5,085,039 - 5,108,706 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	7	5,163,659 - 5,187,282 (+)	NCBI		T2T-CHM13v2.0
CRA_TCAGchr7v2	7	5,131,807 - 5,155,474 (+)	NCBI

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
RBAK	Human	Baraitser-Winter syndrome 1		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Baraitser-Winter syndrome 1	ClinVar	PMID:27633570 more ...
RBAK	Human	megacolon		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Megacolon	ClinVar	PMID:21681106
RBAK	Human	prostate cancer		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Malignant tumor of prostate	ClinVar	PMID:23265383

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
RBAK	Human	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	Rbak (Mus musculus)	6480464	Tetrachlorodibenzodioxin affects the expression of RBAK mRNA	CTD	PMID:21570461
RBAK	Human	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	Rbak (Rattus norvegicus)	6480464	Tetrachlorodibenzodioxin results in increased expression of RBAK mRNA	CTD	PMID:33387578
RBAK	Human	4,4'-diaminodiphenylmethane	increases expression	ISO	Rbak (Mus musculus)	6480464	4 and 4'-diaminodiphenylmethane results in increased expression of RBAK mRNA	CTD	PMID:18648102
RBAK	Human	4-hydroxyphenyl retinamide	increases expression	EXP		6480464	Fenretinide results in increased expression of RBAK mRNA	CTD	PMID:16570282
RBAK	Human	acrylamide	increases expression	EXP		6480464	Acrylamide results in increased expression of RBAK mRNA	CTD	PMID:32763439
RBAK	Human	aflatoxin B1	decreases expression	ISO	Rbak (Rattus norvegicus)	6480464	Aflatoxin B1 results in decreased expression of RBAK mRNA	CTD	PMID:33354967
RBAK	Human	aflatoxin M1	decreases expression	EXP		6480464	Aflatoxin M1 results in decreased expression of RBAK mRNA	CTD	PMID:30928695
RBAK	Human	aristolochic acid A	decreases expression	EXP		6480464	aristolochic acid I results in decreased expression of RBAK mRNA	CTD	PMID:33212167
RBAK	Human	Aroclor 1254	decreases expression	EXP		6480464	Chlorodiphenyl (54% Chlorine) results in decreased expression of RBAK mRNA	CTD	PMID:16934159
RBAK	Human	bisphenol A	affects expression	ISO	Rbak (Rattus norvegicus)	6480464	bisphenol A affects the expression of RBAK mRNA	CTD	PMID:25181051
RBAK	Human	bisphenol A	decreases expression	ISO	Rbak (Rattus norvegicus)	6480464	bisphenol A results in decreased expression of RBAK mRNA	CTD	PMID:34947998
RBAK	Human	bisphenol A	decreases methylation	ISO	Rbak (Rattus norvegicus)	6480464	bisphenol A results in decreased methylation of RBAK gene	CTD	PMID:28505145
RBAK	Human	bisphenol F	decreases expression	ISO	Rbak (Mus musculus)	6480464	bisphenol F results in decreased expression of RBAK mRNA	CTD	PMID:38685157
RBAK	Human	butanal	decreases expression	EXP		6480464	butyraldehyde results in decreased expression of RBAK mRNA	CTD	PMID:26079696
RBAK	Human	carbon nanotube	decreases expression	ISO	Rbak (Mus musculus)	6480464	Nanotubes more ...	CTD	PMID:25554681
RBAK	Human	chlorpyrifos	decreases expression	ISO	Rbak (Mus musculus)	6480464	Chlorpyrifos results in decreased expression of RBAK mRNA	CTD	PMID:37019170
RBAK	Human	copper(II) sulfate	increases expression	EXP		6480464	Copper Sulfate results in increased expression of RBAK mRNA	CTD	PMID:19549813
RBAK	Human	Dibutyl phosphate	affects expression	EXP		6480464	di-n-butylphosphoric acid affects the expression of RBAK mRNA	CTD	PMID:37042841
RBAK	Human	dicrotophos	decreases expression	EXP		6480464	dicrotophos results in decreased expression of RBAK mRNA	CTD	PMID:28302478
RBAK	Human	dorsomorphin	multiple interactions	EXP		6480464	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ...	CTD	PMID:27188386
RBAK	Human	doxorubicin	affects expression	EXP		6480464	Doxorubicin affects the expression of RBAK mRNA	CTD	PMID:29803840
RBAK	Human	ferric oxide	increases expression	ISO	Rbak (Mus musculus)	6480464	ferric oxide analog results in increased expression of RBAK mRNA	CTD	PMID:24525745
RBAK	Human	folic acid	decreases expression	ISO	Rbak (Mus musculus)	6480464	Folic Acid results in decreased expression of RBAK mRNA	CTD	PMID:25629700
RBAK	Human	formaldehyde	decreases expression	EXP		6480464	Formaldehyde results in decreased expression of RBAK mRNA	CTD	PMID:20655997
RBAK	Human	geldanamycin	increases expression	EXP		6480464	geldanamycin results in increased expression of RBAK mRNA	CTD	PMID:26705709
RBAK	Human	gentamycin	decreases expression	ISO	Rbak (Rattus norvegicus)	6480464	Gentamicins results in decreased expression of RBAK mRNA	CTD	PMID:33387578
RBAK	Human	mercury dichloride	decreases expression	EXP		6480464	Mercuric Chloride results in decreased expression of RBAK mRNA	CTD	PMID:27188386
RBAK	Human	methotrexate	affects expression	ISO	Rbak (Mus musculus)	6480464	Methotrexate affects the expression of RBAK mRNA	CTD	PMID:18502557
RBAK	Human	methylmercury chloride	increases expression	EXP		6480464	methylmercuric chloride results in increased expression of RBAK mRNA	CTD	PMID:26272509
RBAK	Human	methylmercury chloride	decreases expression	EXP		6480464	methylmercuric chloride results in decreased expression of RBAK mRNA	CTD	PMID:28001369
RBAK	Human	p-chloromercuribenzoic acid	increases expression	EXP		6480464	p-Chloromercuribenzoic Acid results in increased expression of RBAK mRNA	CTD	PMID:27188386
RBAK	Human	pentanal	decreases expression	EXP		6480464	pentanal results in decreased expression of RBAK mRNA	CTD	PMID:26079696
RBAK	Human	phenylmercury acetate	decreases expression	EXP		6480464	Phenylmercuric Acetate results in decreased expression of RBAK mRNA	CTD	PMID:26272509
RBAK	Human	phenylmercury acetate	multiple interactions	EXP		6480464	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RBAK mRNA	CTD	PMID:27188386
RBAK	Human	pirinixic acid	multiple interactions	ISO	Rbak (Mus musculus)	6480464	[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RBAK mRNA	CTD	PMID:19710929
RBAK	Human	quercitrin	increases expression	EXP		6480464	quercitrin results in increased expression of RBAK mRNA	CTD	PMID:25193878
RBAK	Human	resveratrol	multiple interactions	EXP		6480464	[Plant Extracts co-treated with Resveratrol] results in increased expression of RBAK mRNA	CTD	PMID:23557933
RBAK	Human	SB 431542	multiple interactions	EXP		6480464	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ...	CTD	PMID:27188386
RBAK	Human	sodium arsenite	increases expression	EXP		6480464	sodium arsenite results in increased expression of RBAK mRNA	CTD	PMID:38568856
RBAK	Human	sunitinib	increases expression	EXP		6480464	Sunitinib results in increased expression of RBAK mRNA	CTD	PMID:31533062
RBAK	Human	thimerosal	decreases expression	EXP		6480464	Thimerosal results in decreased expression of RBAK mRNA	CTD	PMID:27188386
RBAK	Human	thiram	increases expression	EXP		6480464	Thiram results in increased expression of RBAK mRNA	CTD	PMID:38568856
RBAK	Human	titanium dioxide	affects expression	ISO	Rbak (Mus musculus)	6480464	titanium dioxide affects the expression of RBAK mRNA	CTD	PMID:17656681
RBAK	Human	titanium dioxide	decreases methylation	ISO	Rbak (Mus musculus)	6480464	titanium dioxide results in decreased methylation of RBAK gene	CTD	PMID:35295148
RBAK	Human	trichostatin A	decreases expression	EXP		6480464	trichostatin A results in decreased expression of RBAK mRNA	CTD	PMID:24935251 and PMID:26272509
RBAK	Human	trichostatin A	multiple interactions	EXP		6480464	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RBAK mRNA	CTD	PMID:27188386
RBAK	Human	triphenyl phosphate	affects expression	EXP		6480464	triphenyl phosphate affects the expression of RBAK mRNA	CTD	PMID:37042841
RBAK	Human	triptonide	decreases expression	ISO	Rbak (Mus musculus)	6480464	triptonide results in decreased expression of RBAK mRNA	CTD	PMID:33045310
RBAK	Human	trovafloxacin	increases expression	ISO	Rbak (Mus musculus)	6480464	trovafloxacin results in increased expression of RBAK mRNA	CTD	PMID:35537566
RBAK	Human	valproic acid	decreases expression	EXP		6480464	Valproic Acid results in decreased expression of RBAK mRNA	CTD	PMID:23179753 more ...
RBAK	Human	valproic acid	multiple interactions	EXP		6480464	[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RBAK mRNA	CTD	PMID:27188386
RBAK	Human	vinclozolin	increases methylation	ISO	Rbak (Rattus norvegicus)	6480464	vinclozolin results in increased methylation of RBAK gene	CTD	PMID:31079544
RBAK	Human	vorinostat	decreases expression	EXP		6480464	vorinostat results in decreased expression of RBAK mRNA	CTD	PMID:27188386

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
RBAK	Human	negative regulation of DNA-templated transcription	involved_in	TAS		150520179	PMID:10702291	UniProt	PMID:10702291
RBAK	Human	regulation of DNA-templated transcription	involved_in	TAS		150520179	PMID:10702291	UniProt	PMID:10702291
RBAK	Human	regulation of DNA-templated transcription	involved_in	IEA	InterPro:IPR001909 and InterPro:IPR036051	150520179		InterPro	GO_REF:0000002
RBAK	Human	regulation of transcription by RNA polymerase II	involved_in	IBA	FB:FBgn0004618 more ...	150520179		GO_Central	GO_REF:0000033

Cellular Component

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
RBAK	Human	nucleoplasm	located_in	IDA		150520179		HPA	GO_REF:0000052
RBAK	Human	nucleus	located_in	IEA	UniProtKB-KW:KW-0539	150520179		UniProt	GO_REF:0000043
RBAK	Human	nucleus	located_in	IEA	UniProtKB-SubCell:SL-0191	150520179		UniProt	GO_REF:0000044
RBAK	Human	nucleus	located_in	TAS		150520179	PMID:10702291	UniProt	PMID:10702291

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
RBAK	Human	DNA-binding transcription factor activity, RNA polymerase II-specific	enables	IBA	FB:FBgn0004618 more ...	150520179		GO_Central	GO_REF:0000033
RBAK	Human	metal ion binding	enables	IEA	UniProtKB-KW:KW-0479	150520179		UniProt	GO_REF:0000043
RBAK	Human	protein binding	enables	IPI	UniProtKB:O95967 more ...	150520179	PMID:32296183	IntAct	PMID:32296183
RBAK	Human	RNA polymerase II cis-regulatory region sequence-specific DNA binding	enables	IBA	MGI:1338823 more ...	150520179		GO_Central	GO_REF:0000033
RBAK	Human	zinc ion binding	enables	NAS		150520179	PMID:10702291	UniProt	PMID:10702291
RBAK	Human	zinc ion binding	enables	IEA	UniProtKB-KW:KW-0863	150520179		UniProt	GO_REF:0000043

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
RBAK	Human	Megacolon		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Megacolon	ClinVar	PMID:21681106
RBAK	Human	Prostate cancer		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Prostatic cancer	ClinVar	PMID:23265383

#	Reference Title	Reference Citation
1.	ClinVar Automated Import and Annotation Pipeline	RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
2.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions

PMID:10702291	PMID:12070015	PMID:12477932	PMID:14664718	PMID:14702039	PMID:16344560	PMID:17121540	PMID:18307725	PMID:19240061	PMID:19274049	PMID:19284880	PMID:20360068
PMID:20466629	PMID:21549307	PMID:21873635	PMID:26186194	PMID:28514442	PMID:28625976	PMID:29180619	PMID:29987050	PMID:32296183	PMID:33321125	PMID:33961781	PMID:34079125
PMID:34189442	PMID:35256949	PMID:35271311	PMID:35563538	PMID:36089195	PMID:36339263

RBAK
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	7	5,045,860 - 5,069,487 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	7	5,045,821 - 5,069,487 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	7	5,085,491 - 5,109,118 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	7	5,052,079 - 5,075,645 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Celera	7	5,044,901 - 5,068,467 (+)	NCBI		Celera
Cytogenetic Map	7	p22.1	NCBI
HuRef	7	5,000,481 - 5,024,148 (+)	NCBI		HuRef
CHM1_1	7	5,085,039 - 5,108,706 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	7	5,163,659 - 5,187,282 (+)	NCBI		T2T-CHM13v2.0
CRA_TCAGchr7v2	7	5,131,807 - 5,155,474 (+)	NCBI

Rbak
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	5	143,157,941 - 143,166,530 (-)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	5	143,157,941 - 143,166,530 (-)	Ensembl		GRCm39 Ensembl
GRCm38	5	143,172,186 - 143,180,775 (-)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	5	143,172,186 - 143,180,775 (-)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	5	143,933,867 - 143,942,422 (-)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	5	143,437,326 - 143,445,915 (-)	NCBI		MGSCv36	mm8
Celera	5	140,216,911 - 140,225,466 (-)	NCBI		Celera
Cytogenetic Map	5	G2	NCBI
cM Map	5	81.98	NCBI

Rbak
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	12	16,488,895 - 16,502,523 (+)	NCBI		GRCr8
mRatBN7.2	12	11,375,314 - 11,388,937 (+)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	12	11,375,318 - 11,388,934 (+)	Ensembl		mRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx	12	12,184,277 - 12,196,488 (+)	NCBI	Rnor_SHR	UTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0	12	12,807,555 - 12,819,766 (+)	NCBI	Rnor_SHRSP	UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0	12	11,833,653 - 11,845,864 (+)	NCBI	Rnor_WKY	UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0	12	13,428,648 - 13,442,279 (+)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	12	13,428,685 - 13,442,286 (+)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	12	15,468,852 - 15,482,466 (+)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	12	11,748,333 - 11,760,544 (+)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
Celera	12	13,168,595 - 13,180,802 (+)	NCBI		Celera
Cytogenetic Map	12	p11	NCBI

RBAK
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	6	10,013,378 - 10,037,654 (+)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	7	58,338,781 - 58,358,815 (+)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	7	5,304,827 - 5,328,372 (+)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	7	5,332,884 - 5,356,307 (+)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	7	5,344,120 - 5,356,307 (+)	Ensembl	panpan1.1		panPan2

RBAK
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	6	12,072,465 - 12,097,422 (+)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	6	12,073,368 - 12,093,811 (+)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	6	18,326,735 - 18,342,501 (-)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	6	12,166,066 - 12,194,774 (+)	NCBI		ROS_Cfam_1.0
UMICH_Zoey_3.1	6	12,033,522 - 12,049,283 (+)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	6	11,954,564 - 11,982,773 (+)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	6	12,207,419 - 12,259,386 (+)	NCBI		UU_Cfam_GSD_1.0

Rbak
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024409344	140,321,392 - 140,339,751 (+)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936765	315,255 - 326,409 (+)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936765	312,474 - 327,089 (+)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

RBAK
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	3	4,422,784 - 4,439,945 (-)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	3	4,422,481 - 4,439,943 (-)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	3	144,137,154 - 144,154,400 (-)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

RBAK
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	28	16,594,449 - 16,648,577 (-)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
Vero_WHO_p1.0	NW_023666090	5,279,291 - 5,326,056 (+)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Rbak
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla_female_1.0 Ensembl	NW_004624740	27,682,835 - 27,701,904 (+)	Ensembl	HetGla_female_1.0	HetGla_female_1.0 Ensembl	hetGla2
HetGla 1.0	NW_004624740	27,681,328 - 27,700,055 (+)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants in RBAK
50 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 7p22.2-22.1(chr7:4469558-5111872)x3	copy number gain	See cases [RCV000050969]	Chr7:4469558..5111872 [GRCh38] Chr7:4509189..5151503 [GRCh37] Chr7:4475715..5118029 [NCBI36] Chr7:7p22.2-22.1	uncertain significance
GRCh38/hg38 7p22.3-14.1(chr7:54185-41875885)x3	copy number gain	See cases [RCV000051159]	Chr7:54185..41875885 [GRCh38] Chr7:54185..41915483 [GRCh37] Chr7:149268..41882008 [NCBI36] Chr7:7p22.3-14.1	pathogenic
GRCh38/hg38 7p22.1(chr7:4532619-5378373)x1	copy number loss	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052255]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052255]\|See cases [RCV000052255]	Chr7:4532619..5378373 [GRCh38] Chr7:4572250..5418004 [GRCh37] Chr7:4538776..5384530 [NCBI36] Chr7:7p22.1	pathogenic
GRCh38/hg38 7p22.1(chr7:5062000-6692258)x1	copy number loss	See cases [RCV000052256]	Chr7:5062000..6692258 [GRCh38] Chr7:5101631..6731889 [GRCh37] Chr7:5068157..6698414 [NCBI36] Chr7:7p22.1	pathogenic
GRCh38/hg38 7p22.1(chr7:5062000-5825183)x1	copy number loss	See cases [RCV000052263]	Chr7:5062000..5825183 [GRCh38] Chr7:5101631..5864814 [GRCh37] Chr7:5068157..5831340 [NCBI36] Chr7:7p22.1	pathogenic
GRCh38/hg38 7p22.3-22.1(chr7:45130-5880375)x1	copy number loss	See cases [RCV000052249]	Chr7:45130..5880375 [GRCh38] Chr7:45130..5920006 [GRCh37] Chr7:140213..5886532 [NCBI36] Chr7:7p22.3-22.1	pathogenic
GRCh38/hg38 7p22.3-q36.3(chr7:53985-159282531)x1	copy number loss	See cases [RCV000052250]	Chr7:53985..159282531 [GRCh38] Chr7:53985..159075220 [GRCh37] Chr7:149068..158767981 [NCBI36] Chr7:7p22.3-q36.3	pathogenic
GRCh38/hg38 7p22.1(chr7:4876621-6492003)x3	copy number gain	See cases [RCV000053408]	Chr7:4876621..6492003 [GRCh38] Chr7:4916252..6531634 [GRCh37] Chr7:4882778..6498159 [NCBI36] Chr7:7p22.1	uncertain significance
GRCh38/hg38 7p22.3-22.1(chr7:45130-6270185)x3	copy number gain	See cases [RCV000053527]	Chr7:45130..6270185 [GRCh38] Chr7:45130..6309816 [GRCh37] Chr7:140213..6276341 [NCBI36] Chr7:7p22.3-22.1	pathogenic
GRCh38/hg38 7p22.3-15.3(chr7:53985-24361531)x3	copy number gain	See cases [RCV000053528]	Chr7:53985..24361531 [GRCh38] Chr7:53985..24401150 [GRCh37] Chr7:149068..24367675 [NCBI36] Chr7:7p22.3-15.3	pathogenic
GRCh38/hg38 7p22.3-21.3(chr7:54185-8274834)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053529]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053529]\|See cases [RCV000053529]	Chr7:54185..8274834 [GRCh38] Chr7:54185..8314464 [GRCh37] Chr7:149268..8280989 [NCBI36] Chr7:7p22.3-21.3	pathogenic
GRCh38/hg38 7p22.3-14.2(chr7:54185-37089712)x3	copy number gain	See cases [RCV000053530]	Chr7:54185..37089712 [GRCh38] Chr7:54185..37129317 [GRCh37] Chr7:149268..37095842 [NCBI36] Chr7:7p22.3-14.2	pathogenic
NM_001204456.1(RBAK):c.891C>T (p.Ser297=)	single nucleotide variant	Malignant melanoma [RCV000067906]	Chr7:5064347 [GRCh38] Chr7:5103978 [GRCh37] Chr7:5070504 [NCBI36] Chr7:7p22.1	not provided
GRCh37/hg19 7p22.1(chr7:4644965-5436368)x3	copy number gain	See cases [RCV000663395]	Chr7:4644965..5436368 [GRCh37] Chr7:7p22.1	likely pathogenic
NM_021163.4(RBAK):c.1602A>T (p.Lys534Asn)	single nucleotide variant	Malignant tumor of prostate [RCV000149282]	Chr7:5065058 [GRCh38] Chr7:5104689 [GRCh37] Chr7:7p22.1	uncertain significance
GRCh38/hg38 7p22.3-q36.3(chr7:54185-159282390)x1	copy number loss	See cases [RCV000135401]	Chr7:54185..159282390 [GRCh38] Chr7:54185..159075079 [GRCh37] Chr7:149268..158767840 [NCBI36] Chr7:7p22.3-q36.3	pathogenic
GRCh38/hg38 7p22.1(chr7:5041361-5126344)x1	copy number loss	See cases [RCV000135240]	Chr7:5041361..5126344 [GRCh38] Chr7:5080992..5165975 [GRCh37] Chr7:5047518..5132501 [NCBI36] Chr7:7p22.1	likely benign
GRCh38/hg38 7p22.3-15.2(chr7:54185-26827634)x3	copy number gain	See cases [RCV000136557]	Chr7:54185..26827634 [GRCh38] Chr7:54185..26867253 [GRCh37] Chr7:149268..26833778 [NCBI36] Chr7:7p22.3-15.2	pathogenic
GRCh38/hg38 7p22.3-22.1(chr7:54185-6638027)x3	copy number gain	See cases [RCV000136731]	Chr7:54185..6638027 [GRCh38] Chr7:54185..6677658 [GRCh37] Chr7:149268..6644183 [NCBI36] Chr7:7p22.3-22.1	pathogenic
GRCh38/hg38 7p22.3-21.3(chr7:45130-7252065)x3	copy number gain	See cases [RCV000137524]	Chr7:45130..7252065 [GRCh38] Chr7:45130..7291696 [GRCh37] Chr7:140213..7258221 [NCBI36] Chr7:7p22.3-21.3	pathogenic
GRCh38/hg38 7p22.3-15.3(chr7:45130-25221165)x3	copy number gain	See cases [RCV000137824]	Chr7:45130..25221165 [GRCh38] Chr7:45130..25260784 [GRCh37] Chr7:140213..25227309 [NCBI36] Chr7:7p22.3-15.3	pathogenic
GRCh38/hg38 7p22.1(chr7:4849987-5760088)x3	copy number gain	See cases [RCV000137977]	Chr7:4849987..5760088 [GRCh38] Chr7:4889618..5799719 [GRCh37] Chr7:4856144..5766245 [NCBI36] Chr7:7p22.1	likely pathogenic
GRCh38/hg38 7p22.1(chr7:4922492-5112002)x3	copy number gain	See cases [RCV000139600]	Chr7:4922492..5112002 [GRCh38] Chr7:4962123..5151633 [GRCh37] Chr7:4928649..5118159 [NCBI36] Chr7:7p22.1	likely benign
GRCh38/hg38 7p22.3-15.2(chr7:1698124-27207295)x3	copy number gain	See cases [RCV000143060]	Chr7:1698124..27207295 [GRCh38] Chr7:1737760..27246914 [GRCh37] Chr7:1704286..27213439 [NCBI36] Chr7:7p22.3-15.2	pathogenic
GRCh38/hg38 7p22.3-15.2(chr7:43360-27196404)x3	copy number gain	See cases [RCV000143586]	Chr7:43360..27196404 [GRCh38] Chr7:43360..27236023 [GRCh37] Chr7:138443..27202548 [NCBI36] Chr7:7p22.3-15.2	pathogenic
GRCh37/hg19 7p22.3-q36.3(chr7:43360-159119707)x1	copy number loss	See cases [RCV000446044]	Chr7:43360..159119707 [GRCh37] Chr7:7p22.3-q36.3	pathogenic
GRCh37/hg19 7p22.3-22.1(chr7:43360-5443709)x3	copy number gain	See cases [RCV000449281]	Chr7:43360..5443709 [GRCh37] Chr7:7p22.3-22.1	pathogenic
GRCh37/hg19 7p22.3-21.3(chr7:183556-12746636)x3	copy number gain	See cases [RCV000449446]	Chr7:183556..12746636 [GRCh37] Chr7:7p22.3-21.3	pathogenic
GRCh37/hg19 7p22.3-21.1(chr7:43360-17656861)x3	copy number gain	See cases [RCV000449347]	Chr7:43360..17656861 [GRCh37] Chr7:7p22.3-21.1	pathogenic
GRCh37/hg19 7p22.1(chr7:4743281-5163491)x1	copy number loss	See cases [RCV000448545]	Chr7:4743281..5163491 [GRCh37] Chr7:7p22.1	likely benign
GRCh37/hg19 7p22.3-15.3(chr7:43360-23674928)x3	copy number gain	See cases [RCV000510652]	Chr7:43360..23674928 [GRCh37] Chr7:7p22.3-15.3	pathogenic
GRCh37/hg19 7p22.3-14.3(chr7:704573-29257946)x3	copy number gain	See cases [RCV000510275]	Chr7:704573..29257946 [GRCh37] Chr7:7p22.3-14.3	pathogenic
GRCh37/hg19 7p22.3-q36.3(chr7:43361-159119707)	copy number gain	See cases [RCV000510686]	Chr7:43361..159119707 [GRCh37] Chr7:7p22.3-q36.3	pathogenic
GRCh37/hg19 7p22.1(chr7:4839046-7110343)x3	copy number gain	See cases [RCV000511909]	Chr7:4839046..7110343 [GRCh37] Chr7:7p22.1	likely pathogenic
GRCh37/hg19 7p22.3-21.2(chr7:43360-14664158)x3	copy number gain	See cases [RCV000511772]	Chr7:43360..14664158 [GRCh37] Chr7:7p22.3-21.2	pathogenic
GRCh37/hg19 7p22.3-q36.3(chr7:43361-159119707)x3	copy number gain	See cases [RCV000511549]	Chr7:43361..159119707 [GRCh37] Chr7:7p22.3-q36.3	pathogenic
GRCh37/hg19 7p22.3-21.3(chr7:43360-12098696)x3	copy number gain	See cases [RCV000510950]	Chr7:43360..12098696 [GRCh37] Chr7:7p22.3-21.3	pathogenic
GRCh37/hg19 7p22.3-21.3(chr7:2789546-9066894)x3	copy number gain	See cases [RCV000515563]	Chr7:2789546..9066894 [GRCh37] Chr7:7p22.3-21.3	pathogenic
GRCh37/hg19 7p22.3-21.3(chr7:43360-11567351)x3	copy number gain	See cases [RCV000512505]	Chr7:43360..11567351 [GRCh37] Chr7:7p22.3-21.3	pathogenic
GRCh37/hg19 7p22.3-22.1(chr7:1201674-5175651)x1	copy number loss	See cases [RCV000512351]	Chr7:1201674..5175651 [GRCh37] Chr7:7p22.3-22.1	pathogenic
GRCh37/hg19 7p22.2-21.3(chr7:4388620-7302293)x3	copy number gain	not provided [RCV000682900]	Chr7:4388620..7302293 [GRCh37] Chr7:7p22.2-21.3	pathogenic
GRCh37/hg19 7p22.3-q36.3(chr7:44935-159126310)x3	copy number gain	not provided [RCV000746280]	Chr7:44935..159126310 [GRCh37] Chr7:7p22.3-q36.3	pathogenic
GRCh37/hg19 7p22.3-q36.3(chr7:10704-159122532)x3	copy number gain	not provided [RCV000746278]	Chr7:10704..159122532 [GRCh37] Chr7:7p22.3-q36.3	pathogenic
GRCh37/hg19 7p22.3-21.3(chr7:10239-13116278)x3	copy number gain	not provided [RCV000746277]	Chr7:10239..13116278 [GRCh37] Chr7:7p22.3-21.3	pathogenic
GRCh37/hg19 7p22.1(chr7:5066179-5203597)x1	copy number loss	not provided [RCV001005898]	Chr7:5066179..5203597 [GRCh37] Chr7:7p22.1	likely benign
GRCh37/hg19 7p22.3-q36.3(chr7:10365-159119707)x3	copy number gain	not provided [RCV000848126]	Chr7:10365..159119707 [GRCh37] Chr7:7p22.3-q36.3	pathogenic
GRCh37/hg19 7p22.3-21.1(chr7:43376-19520619)x3	copy number gain	not provided [RCV000848100]	Chr7:43376..19520619 [GRCh37] Chr7:7p22.3-21.1	pathogenic
GRCh37/hg19 7p22.3-21.3(chr7:1648373-10627513)x3	copy number gain	not provided [RCV001005891]	Chr7:1648373..10627513 [GRCh37] Chr7:7p22.3-21.3	pathogenic
GRCh37/hg19 7p22.2-22.1(chr7:4457599-5138409)x3	copy number gain	not provided [RCV001259990]	Chr7:4457599..5138409 [GRCh37] Chr7:7p22.2-22.1	uncertain significance
GRCh37/hg19 7p22.1(chr7:4733073-5157165)x3	copy number gain	not provided [RCV001259438]	Chr7:4733073..5157165 [GRCh37] Chr7:7p22.1	uncertain significance
Single allele	complex	Ring chromosome 7 [RCV002280646]	Chr7:43360..159119707 [GRCh37] Chr7:7p22.3-q36.3	pathogenic
GRCh37/hg19 7p22.1(chr7:5096876-5569338)x1	copy number loss	Astigmatism [RCV001801207]	Chr7:5096876..5569338 [GRCh37] Chr7:7p22.1	pathogenic
NC_000007.13:g.4929022_5218030dup	duplication	Megacolon [RCV001290077]	Chr7:4929022..5218030 [GRCh37] Chr7:7p22.1	uncertain significance
GRCh37/hg19 7p22.1(chr7:4953918-5184301)x3	copy number gain	not provided [RCV001834455]	Chr7:4953918..5184301 [GRCh37] Chr7:7p22.1	uncertain significance
NC_000007.13:g.(?_4815347)_(5792630_?)dup	duplication	Baraitser-Winter syndrome 1 [RCV001978085]	Chr7:4815347..5792630 [GRCh37] Chr7:7p22.1	uncertain significance
GRCh37/hg19 7p22.3-21.1(chr7:43360-19485604)x3	copy number gain	See cases [RCV002287567]	Chr7:43360..19485604 [GRCh37] Chr7:7p22.3-21.1	pathogenic
GRCh37/hg19 7p22.3-q36.3(chr7:56604613-96692931)x1	copy number loss	See cases [RCV002287832]	Chr7:56604613..96692931 [GRCh37] Chr7:7p22.3-q36.3	uncertain significance
GRCh37/hg19 7p22.3-21.3(chr7:43360-9649794)x3	copy number gain	See cases [RCV002292426]	Chr7:43360..9649794 [GRCh37] Chr7:7p22.3-21.3	pathogenic
NM_021163.4(RBAK):c.1688A>G (p.Glu563Gly)	single nucleotide variant	not specified [RCV004317966]	Chr7:5065144 [GRCh38] Chr7:5104775 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.1465G>C (p.Glu489Gln)	single nucleotide variant	not specified [RCV004323825]	Chr7:5064921 [GRCh38] Chr7:5104552 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.1711G>A (p.Glu571Lys)	single nucleotide variant	not specified [RCV004288199]	Chr7:5065167 [GRCh38] Chr7:5104798 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.922C>T (p.Arg308Trp)	single nucleotide variant	not specified [RCV004084513]	Chr7:5064378 [GRCh38] Chr7:5104009 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.550G>T (p.Gly184Trp)	single nucleotide variant	not specified [RCV004106325]	Chr7:5064006 [GRCh38] Chr7:5103637 [GRCh37] Chr7:7p22.1	uncertain significance
GRCh37/hg19 7p22.1(chr7:4868426-5184301)x3	copy number gain	not provided [RCV002475697]	Chr7:4868426..5184301 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.772A>G (p.Met258Val)	single nucleotide variant	not specified [RCV004210636]	Chr7:5064228 [GRCh38] Chr7:5103859 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.246G>C (p.Trp82Cys)	single nucleotide variant	not specified [RCV004127355]	Chr7:5063702 [GRCh38] Chr7:5103333 [GRCh37] Chr7:7p22.1	uncertain significance
GRCh37/hg19 7p22.1(chr7:4655928-5990874)x1	copy number loss	not provided [RCV002475747]	Chr7:4655928..5990874 [GRCh37] Chr7:7p22.1	pathogenic
NM_021163.4(RBAK):c.1369T>C (p.Tyr457His)	single nucleotide variant	not specified [RCV004190652]	Chr7:5064825 [GRCh38] Chr7:5104456 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.1571C>T (p.Ser524Leu)	single nucleotide variant	not specified [RCV004111269]	Chr7:5065027 [GRCh38] Chr7:5104658 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.326C>A (p.Thr109Asn)	single nucleotide variant	not specified [RCV004110362]	Chr7:5063782 [GRCh38] Chr7:5103413 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.1481C>T (p.Ser494Phe)	single nucleotide variant	not specified [RCV004178203]	Chr7:5064937 [GRCh38] Chr7:5104568 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.761C>T (p.Ser254Leu)	single nucleotide variant	not specified [RCV004069158]	Chr7:5064217 [GRCh38] Chr7:5103848 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.290A>G (p.Lys97Arg)	single nucleotide variant	not specified [RCV004244203]	Chr7:5063746 [GRCh38] Chr7:5103377 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.923G>A (p.Arg308Gln)	single nucleotide variant	not specified [RCV004075883]	Chr7:5064379 [GRCh38] Chr7:5104010 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.631A>T (p.Met211Leu)	single nucleotide variant	not specified [RCV004082247]	Chr7:5064087 [GRCh38] Chr7:5103718 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.716G>A (p.Gly239Glu)	single nucleotide variant	not specified [RCV004150619]	Chr7:5064172 [GRCh38] Chr7:5103803 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.1841A>G (p.His614Arg)	single nucleotide variant	not specified [RCV004098354]	Chr7:5065297 [GRCh38] Chr7:5104928 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.1123T>C (p.Cys375Arg)	single nucleotide variant	not specified [RCV004180536]	Chr7:5064579 [GRCh38] Chr7:5104210 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.1733A>G (p.His578Arg)	single nucleotide variant	not specified [RCV004314186]	Chr7:5065189 [GRCh38] Chr7:5104820 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.1427G>A (p.Arg476Gln)	single nucleotide variant	not specified [RCV004255214]	Chr7:5064883 [GRCh38] Chr7:5104514 [GRCh37] Chr7:7p22.1	uncertain significance
GRCh37/hg19 7p22.1(chr7:4909470-5331753)x3	copy number gain	not provided [RCV003484675]	Chr7:4909470..5331753 [GRCh37] Chr7:7p22.1	uncertain significance
GRCh37/hg19 7p22.3-22.1(chr7:43361-5965440)x3	copy number gain	not provided [RCV003484666]	Chr7:43361..5965440 [GRCh37] Chr7:7p22.3-22.1	pathogenic
GRCh37/hg19 7p22.3-21.3(chr7:43361-8890475)x3	copy number gain	not provided [RCV003484665]	Chr7:43361..8890475 [GRCh37] Chr7:7p22.3-21.3	pathogenic
NM_021163.4(RBAK):c.2040A>G (p.Glu680=)	single nucleotide variant	not provided [RCV003433736]	Chr7:5065496 [GRCh38] Chr7:5105127 [GRCh37] Chr7:7p22.1	likely benign
NM_021163.4(RBAK):c.2113A>G (p.Asn705Asp)	single nucleotide variant	not specified [RCV004440979]	Chr7:5065569 [GRCh38] Chr7:5105200 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.727A>T (p.Ile243Leu)	single nucleotide variant	not specified [RCV004440981]	Chr7:5064183 [GRCh38] Chr7:5103814 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.869A>C (p.Glu290Ala)	single nucleotide variant	not specified [RCV004440982]	Chr7:5064325 [GRCh38] Chr7:5103956 [GRCh37] Chr7:7p22.1	likely benign
NM_021163.4(RBAK):c.1679G>A (p.Ser560Asn)	single nucleotide variant	not specified [RCV004440976]	Chr7:5065135 [GRCh38] Chr7:5104766 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.1813T>C (p.Ser605Pro)	single nucleotide variant	not specified [RCV004440977]	Chr7:5065269 [GRCh38] Chr7:5104900 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.1376G>C (p.Cys459Ser)	single nucleotide variant	not specified [RCV004440972]	Chr7:5064832 [GRCh38] Chr7:5104463 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.1646A>G (p.Asn549Ser)	single nucleotide variant	not specified [RCV004440974]	Chr7:5065102 [GRCh38] Chr7:5104733 [GRCh37] Chr7:7p22.1	likely benign
NM_021163.4(RBAK):c.2028G>C (p.Glu676Asp)	single nucleotide variant	not specified [RCV004440978]	Chr7:5065484 [GRCh38] Chr7:5105115 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.1550G>C (p.Gly517Ala)	single nucleotide variant	not specified [RCV004660717]	Chr7:5065006 [GRCh38] Chr7:5104637 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.437C>G (p.Ser146Cys)	single nucleotide variant	not specified [RCV004660720]	Chr7:5063893 [GRCh38] Chr7:5103524 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.343G>A (p.Glu115Lys)	single nucleotide variant	not specified [RCV004660718]	Chr7:5063799 [GRCh38] Chr7:5103430 [GRCh37] Chr7:7p22.1	uncertain significance
NC_000007.13:g.(?_4815347)_(5792630_?)del	deletion	Baraitser-Winter syndrome 1 [RCV004583510]	Chr7:4815347..5792630 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.2032C>T (p.Pro678Ser)	single nucleotide variant	not specified [RCV004860644]	Chr7:5065488 [GRCh38] Chr7:5105119 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.1446G>C (p.Glu482Asp)	single nucleotide variant	not specified [RCV004860645]	Chr7:5064902 [GRCh38] Chr7:5104533 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.299G>A (p.Arg100Lys)	single nucleotide variant	not specified [RCV004860640]	Chr7:5063755 [GRCh38] Chr7:5103386 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.890C>G (p.Ser297Cys)	single nucleotide variant	not specified [RCV004860638]	Chr7:5064346 [GRCh38] Chr7:5103977 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.2075C>T (p.Ser692Leu)	single nucleotide variant	not specified [RCV004860642]	Chr7:5065531 [GRCh38] Chr7:5105162 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.574G>A (p.Glu192Lys)	single nucleotide variant	not specified [RCV004860639]	Chr7:5064030 [GRCh38] Chr7:5103661 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.1252A>G (p.Thr418Ala)	single nucleotide variant	not specified [RCV004854511]	Chr7:5064708 [GRCh38] Chr7:5104339 [GRCh37] Chr7:7p22.1	uncertain significance
GRCh37/hg19 7p22.1(chr7:4756391-5934779)x3	copy number gain	See cases [RCV000448466]	Chr7:4756391..5934779 [GRCh37] Chr7:7p22.1	uncertain significance
GRCh37/hg19 7p22.1(chr7:4859257-5167160)x3	copy number gain	not provided [RCV000746401]	Chr7:4859257..5167160 [GRCh37] Chr7:7p22.1	benign
NM_021163.4(RBAK):c.2048A>G (p.Glu683Gly)	single nucleotide variant	not specified [RCV004336692]	Chr7:5065504 [GRCh38] Chr7:5105135 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.1350T>A (p.Ser450Arg)	single nucleotide variant	not specified [RCV004342730]	Chr7:5064806 [GRCh38] Chr7:5104437 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.1655C>T (p.Ser552Leu)	single nucleotide variant	not specified [RCV004440975]	Chr7:5065111 [GRCh38] Chr7:5104742 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.1502A>G (p.His501Arg)	single nucleotide variant	not specified [RCV004440973]	Chr7:5064958 [GRCh38] Chr7:5104589 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.598A>G (p.Ile200Val)	single nucleotide variant	not specified [RCV004440980]	Chr7:5064054 [GRCh38] Chr7:5103685 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.1840C>T (p.His614Tyr)	single nucleotide variant	not specified [RCV004660719]	Chr7:5065296 [GRCh38] Chr7:5104927 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.698A>G (p.Tyr233Cys)	single nucleotide variant	not specified [RCV004860643]	Chr7:5064154 [GRCh38] Chr7:5103785 [GRCh37] Chr7:7p22.1	uncertain significance
NM_021163.4(RBAK):c.983A>G (p.Gln328Arg)	single nucleotide variant	not specified [RCV004854510]	Chr7:5064439 [GRCh38] Chr7:5104070 [GRCh37] Chr7:7p22.1	uncertain significance

Predicted Target Of

	Summary Value
Count of predictions:	2889
Count of miRNA genes:	1067
Interacting mature miRNAs:	1278
Transcripts:	ENST00000353796, ENST00000396904, ENST00000396912, ENST00000407184, ENST00000476992, ENST00000498308
Prediction methods:	Microtar, Miranda, Rnahybrid
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
1643402	BMD2_H	Bone mineral density QTL 2 (human)	2.69	0.0002	Bone mineral density		7	1	22435431	Human
1643247	BW130_H	Body Weight QTL 130 (human)	1.28	0.008	Body weight	body mass index	7	1	17453493	Human
1643391	BW322_H	Body weight QTL 322 (human)	2.69	0.0002	Body fat amount		7	1	22435431	Human

RH12523

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	7	5,108,949 - 5,109,079	UniSTS	GRCh37
Build 36	7	5,075,475 - 5,075,605	RGD	NCBI36
Celera	7	5,068,297 - 5,068,427	RGD
Cytogenetic Map	7	p22.1	UniSTS
HuRef	7	5,023,978 - 5,024,108	UniSTS
CRA_TCAGchr7v2	7	5,155,304 - 5,155,434	UniSTS
GeneMap99-GB4 RH Map	7	31.6	UniSTS
NCBI RH Map	7	88.2	UniSTS

RBAK_3666

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	7	5,106,105 - 5,106,870	UniSTS	GRCh37
Build 36	7	5,072,631 - 5,073,396	RGD	NCBI36
Celera	7	5,065,453 - 5,066,218	RGD
HuRef	7	5,021,134 - 5,021,899	UniSTS
CRA_TCAGchr7v2	7	5,152,460 - 5,153,225	UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

Download All Expressed Objects for this Gene

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	pharyngeal arch	renal system	reproductive system	respiratory system	sensory system	visual system
1204	2439	2788	2253	4974	1726	2351	6	624	1951	465	2270	7306	6472	53	3734	1	852	1744	1617	175	1


RefSeq Transcripts	NG_047174	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_001204456	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_021163	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AC092032	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK093275	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK293069	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL711327	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC136675	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC136676	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CD238907	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471144	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068271	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DB363461	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	HF584168	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000353796 ⟹ ENSP00000275423

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	7	5,045,821 - 5,067,257 (+)	Ensembl

Ensembl Acc Id:

ENST00000396912 ⟹ ENSP00000380120

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	7	5,045,860 - 5,069,487 (+)	Ensembl

Ensembl Acc Id:

ENST00000476992

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	7	5,056,987 - 5,063,875 (+)	Ensembl

RefSeq Acc Id:

NM_001204456 ⟹ NP_001191385

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	7	5,045,860 - 5,069,487 (+)	NCBI
GRCh37	7	5,085,452 - 5,109,119 (+)	ENTREZGENE
HuRef	7	5,000,481 - 5,024,148 (+)	ENTREZGENE
CHM1_1	7	5,085,039 - 5,108,706 (+)	NCBI
T2T-CHM13v2.0	7	5,163,659 - 5,187,282 (+)	NCBI
CRA_TCAGchr7v2	7	5,131,807 - 5,155,474 (+)	ENTREZGENE

Sequence:

show sequence

ACTGCCCTCGCTTCCTGTGCGTCCTCAGGTCACCGCTTGCTCTAGTTCCCAGGCTTTGGCCTCCAGTGGACGAGAATCGCGGAGCCTGCGGGGCTGGAGGCCCGGCCCGGGCCCCTCGGGAGCAGAAC
AACCTTAGTGAGGTGGACAGGAGGGGACCTCGCGAGCAGACGCGCGCCAGCGACAGCAGCCCCGCCCCGGCCTCTCGGGAGCCGTGGGGCAGAGGCTGCGGAGCCCCAGAAGGGTCTACCAGCCACAG
TCTCTGCACGTTTCCAAGAGCAGCAGAAAATGAACACATTGCAGGGGCCAGTGTCATTCAAAGATGTGGCTGTGGATTTCACCCAGGAGGAGTGGCAGCAGCTGGACCCTGATGAGAAGATAACTTAC
AGGGATGTGATGTTGGAGAACTATAGCCATCTAGTTTCTGTGGGATATGATACCACCAAGCCAAACGTCATCATTAAGTTGGAGCAGGGAGAGGAGCCGTGGATAATGGGAGGTGAATTTCCATGTCA
ACATAGTCCAGAAGCCTGGAGAGTTGATGACCTGATAGAGAGAATCCAAGAAAACGAAGACAAACATTCAAGGCAAGCTGCTTGTATCAATAGCAAAACCCTGACTGAAGAGAAAGAGAATACATTTA
GTCAAATTTACATGGAAACAAGCCTTGTTCCTTCAAGCATAATAGCTCATAATTGTGTCTCATGTGGAAAGAATTTAGAATCTATTTCGCAATTAATTAGTAGTGATGGAAGCTATGCTAGGACAAAA
CCTGATGAGTGTAATGAATGTGGGAAAACATATCATGGAGAGAAAATGTGTGAATTTAATCAAAATGGGGATACCTATTCTCACAATGAAGAAAATATTCTTCAGAAAATTAGTATTTTGGAGAAACC
CTTTGAATATAATGAATGCATGGAAGCCTTAGACAATGAGGCTGTTTTTATTGCTCATAAGAGAGCTTACATAGGGGAGAAGCCCTATGAGTGGAATGATTCTGGACCAGACTTCATACAGATGTCAA
ATTTTAATGCATATCAGAGATCACAAATGGAAATGAAGCCCTTTGAATGCAGTGAATGTGGAAAATCCTTCTGTAAAAAGTCAAAATTCATCATCCACCAGAGGGCTCACACAGGAGAGAAACCTTAT
GAATGTAATGTATGTGGGAAATCCTTCAGCCAAAAGGGAACCCTCACTGTACATCGGAGATCACACTTAGAGGAGAAGCCCTATAAATGTAATGAATGTGGGAAAACCTTTTGTCAGAAGTTACACCT
CACTCAACACCTAAGAACTCATTCAGGAGAGAAACCCTACGAATGTAGCGAATGTGGGAAAACCTTCTGCCAAAAGACACATCTCACCCTGCACCAGAGGAATCATTCAGGAGAGAGGCCCTATCCAT
GTAACGAATGTGGGAAATCCTTCTCCCGCAAGTCTGCTCTCAGTGACCATCAGAGAACTCACACGGGAGAGAAGCTTTATAAATGTAATGAATGTGGGAAATCCTACTACCGAAAGTCTACTCTGATT
ACACATCAGAGAACACACACGGGAGAGAAGCCCTATCAGTGTAGCGAGTGTGGGAAATTCTTTTCTCGGGTGTCATACCTCACTATACATTATAGAAGTCATTTAGAAGAGAAACCCTATGAATGTAA
TGAATGTGGCAAAACCTTCAATTTAAATTCAGCCTTCATTAGACATCGGAAAGTACACACAGAAGAGAAATCCCATGAATGTAGTGAATGTGGAAAGTTCTCTCAGTTGTATCTCACCGACCATCATA
CAGCTCATTTAGAAGAGAAACCCTATGAATGTAATGAATGTGGGAAAACCTTCCTTGTAAATTCAGCCTTCGATGGGCACCAGCCACTTCCAAAAGGGGAGAAATCCTATGAATGTAATGTATGTGGA
AAGTTATTCAATGAGTTGTCATACTATACTGAACATTATAGAAGTCATTCAGAAGAGAAACCTTATGGATGTAGCGAATGTGGGAAAACCTTTTCCCATAATTCATCCCTCTTCAGACATCAAAGAGT
ACACACAGGCGAGAAACCCTATGAATGTTACGAATGTGGAAAATTCTTCTCTCAGAAATCATATCTCACTATACATCATCGAATTCATTCAGGAGAGAAACCCTATGAATGTAGTAAATGTGGAAAAG
TCTTCTCTCGGATGTCAAACCTCACTGTCCACTACAGAAGCCATTCAGGAGAGAAACCCTATGAATGTAATGAATGTGGGAAAGTCTTTTCTCAGAAGTCATACCTCACTGTACACTATAGAACTCAT
TCAGGAGAGAAACCCTATGAATGTAACGAGTGTGGGAAAAAATTCCACCACAGATCAGCCTTCAATAGCCATCAGAGAATTCATAGAAGAGGAAATATGAACGTACTTGATGTGGAAAATCTCTGAAG
TCAGATCTCAATTTTTAGAAAACTCTCTGAATATAATGAATATGGGGAATCCAATAGGAAGTCAAAGCGTTTATCTGAGAGTTCGTGTTCCTGAACGGTGAGAAGCATTTAGGCATTAGAGTCATTTT
AATCCAAATTTTCACAGAGAAGAATCCCGAAGAATGTAACAAGAAGCAAAGCCTTCAGCAAGATCATACGACTCATCGGACACTAATTTATATAGGAGTGAAGTTTTATAAATATTTAATATTTATTT
TGGATTCAAATTGTATTTACATATCAGGGAATCATACAAAGGCAAAATCTGTCAATATGGTGAATGTGGAAAATATATTGTCTTGGAAATTTGTTGTAAAAGCCATATTTCTAATGGAAAATCAGGTG
TTTACAGGAAAGATCTCAGAGGCTATGAGCTCTGAATAAATCTTCATTGTATAAAATGAAGTTTTTAAATTGTCAGGAGTTGATCATGAGGACAGTAGCATTAAATAAGTATATGGCCGTTTTTTATC
ATGTCTTAAAAATGCAATCTAATGGTAATTCTATGCAAGTTTGGAATTGGATGACTTGTGAAGAGGCAGTTTTCTTATTTGAGTATTAGGATGGCAAAATGTATTAAGACAGGACATATTGTTGGTGA
GATAATATTTAATAGGTATAAAATGGTAAAATACCTAGTTTTCTATTTAGAGGAATTTACAAATGGGTTTTTAACAAATGCCTCATTAGTACAGGAGGCAGTCGTTTTGTAAAGTTTTCAACTGCATC
TGAGTAAGATAAGATTTTCTAAAAGACTATTTTGATAAACTATACATACATAATTTGGAATTGTTTAAGTCTATTTCAGTGAAAGAGAACAAGCATACTGCCCATACTCTAAAATATCCCCAGCTCTC
ACACCACCCTTGTTTTTTAACCCATAGGTTTGAGTGTGCCTAGTGCCAATATTTTGTAATTTAGAAATTTTATTCACAAACTTCTGTTTGGTACAAATACAGTGTCATTGTTTTGTGCATTCTCCTTT
TTCCCAGTATTTCAGAACAAATTGATTCAAGTTTCTAGCAGATATTTTTTGATCAATTAACTTAATGTCCTCGCTCCATTTCTTGCTGGAACAGTTTAGGTACCTACCACTTCTTCACATGACACAGG
GGAATCCTGATTAGTCAAAATAATAATGATTTCATTCTCTTTGCCAGTAACTTGTTTTATAGTGGTCATATGACCTGATACTGGGTAAACAAAACAAAGATGGACTTGTTCTGGGAAAAGGTAAAATG
GTAATCAAATAGATTGTGTTCCAGGAATGCAAAGGTGGCTTAATATTCACAAGTCAGTTGCTATTATACACCACCTGTAGAAAAGTAATCTGGCATGCAGAACATTCTTGTGGTACAATTAATGTTCG
TTTATGATCTTAGCAAATGATGGATTGAAAGGGACTTACTTAACTGCATAAAGAGACTTAAACTACAACAAACAATATGCTTAATGATGAAATAGTGAACATTTCTCCTAAGATTATAAAAATAAGAC
AAGGATATCTGCTGTCAATGATTTTATTCGGCATTGTTCAGAAGGACCTAACCAGAAAACTAATGCAAGGAAGAGAAACAAAAGGCATAGAGATTAGAAAAGAAGTAAAACTTTAAAAACGAAAAAGA
ATATAAATCTCTATTTGCAGATGCCATGAGTAAATTTGGTAAGTTCCCTGCATAAAAGTTATGCAAAAAGCATTTTATGATATACCAGCAAAAAACATGGAAAATGAAATTTTGAAAAGCAATGCCAC
TTCAAAGATCCCTCAAGTGCCTAGAGGGAGAAAATGAGTTAATATGCTTTGAAGAACTGTATCCAGAAAATAAAATTACAAAGGAGGAGAGGGATAGGATTCCAGGACAATCTCAAAACTATTGCTTT
TTCCTAAATTCATTGCAACCTTAAAATCCTAGCAAGTTCTTTAATGTAAATTAACAAGCTAATTCTAGAATTCATATGCATATTCAAAAGTCGAATAATTGTCAAGGCTATCCTGTAGAATGGACAGA
GAGGATTGAAATTTCTAAATATCAAGACCTGTTATAAAGCCATAGAAATAATGAAGGTGTTAATTTGGCACAAGGATGAAAAAACTGACTAGTGGAACAGCATACAGATTCAAAAGTAGACCCACGTG
TATACCATCACCTGAGTTTTGAGAAAGGTGACATTGAAGTGTAGTGGGGGAAAGGGTGTTCTTTCCAGTAAATGTACTTTGCCAATAAAATTTTGTAATTTGATAAAAAGTTATTTGGAGGTGGATTG
CAGATCTGAATATGAAATGTGAAAGCTTTACAAAGAAATCTTAGGACAGTTTGTAATCTTGGAGTAAGCAAAGGTTTATTGAGACCCAAAAAGCATTAACCCATAAAATTAGAACTTAATATTAAATT
TGAGAACTTCTATTTATCAGAAAGACCACCAGTAAGAAAATGAACAGGAAATCATGGGGAGGAGAAGATATTTGCAGTTCATGTATGTGACAACAGCACCGAGTATAGCAGAAGTGTTGGCAAACTTT
ATAAAGCAAGGCACCAGATGGTGAAAATTTTCAGCTTTGTCACAACTGCTCATCTTTGCTATTGTGTGAAAGCATCCATACACCATGCATTAAAAAAAAAATGAGCATGGCTGCTTCCCAGTAAAACC
ATTCACAATCCCAGGTGGCAGTCTGGATTTGGTCTGCACTCATAGTTTTCTGGTCCCTGATCTCGAATATGTAAAGAGCACCTACAAATCAACAAGGGGGAAACTGGAAAAGGCAAAAGACTTTAGAG
GATATCCACTCACTTTAGAGGATATCCAGACGGCCAATAAGCATGAAAAGATGTGTTAGCTTTATTAGTAATCAGGGAAATGCAAACTTAAAACATGTAGCACTGCTACCCATCCATGGAAATGGTTA
AAATGAAAAGCATGAAAAAGCATCACGTTTTGGCAAGGATGTAAGCAAGAGGAACTGTACACTACTGGTGGAATTGCTCATCGATAAAACCATTTTGAAAGCTGGCACTAAAAGCCAAGCATATGTAT
ACTGTTTTACCCAAACCCAGCAAAAATGCATGTGTCTGTCCACCAAAGGACATGCACTAGAATATTTATAGCCTAAAACTGCACAAAACAGAACTATCTTAAGGCACATGTGCAATGGAATGAATAAA
GAAGTGGCATATGTCCATGGAATACTGTAAAACAGTGAGCATGAATGAACTAGAAGTCCGTGTAATAACGCAGCTGAATTTAACAAACCTTGCTGAATGAAAGACTCCAGACACAAAAGCCAACATGC
TGTATGATTCCTTCTATATAAATTATAAAGACGGGCAAAACTTGTATACGTGGTTTAAAATTAGGGTAGCAGTTAGCCTTGGCCAAGGCTGAAAGGGGGCATTTATCTGGTGCTGGGAATAATCTGTT
TCTAAACCTAGGTGCTAAGTATTTGAGTGTGTTTTGAGCTGTGCACTTAAGATATGTGTATTTTTCTGCATGTGTGTTAAACTTTCCATAAAAGTTTTCTAAAATCACAAATGGCTAACATTTGTGTC
GCTCATCACTCTAATCATATTTTTCTAGATGTGTATGAATATGCTGCACAACAGGAATTAAATGGCAGATTTTGCATAATTCTGTGCAGGAAATACATATTTATAGTAATTTTGATGGCAACTACTAA
GATTTCCTACGCTGTCCTTAAAGCTTAGCATAATGTATATTTTAAGTGAAATATTTGAGAAGGTTAAAGAATCATTACATACTTTGTCATCCTATACTTTTGCATATATAAATAGGTCTGAGCTGCCT
CTTCAATAAAGAAGCTAATGTGTAACATTTCATATTTCCCTAAA

hide sequence

RefSeq Acc Id:

NM_021163 ⟹ NP_066986

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	7	5,045,860 - 5,069,487 (+)	NCBI
GRCh37	7	5,085,452 - 5,109,119 (+)	ENTREZGENE
Build 36	7	5,052,079 - 5,075,645 (+)	NCBI Archive
Celera	7	5,044,901 - 5,068,467 (+)	RGD
HuRef	7	5,000,481 - 5,024,148 (+)	ENTREZGENE
CHM1_1	7	5,085,140 - 5,108,706 (+)	NCBI
T2T-CHM13v2.0	7	5,163,659 - 5,187,282 (+)	NCBI
CRA_TCAGchr7v2	7	5,131,807 - 5,155,474 (+)	ENTREZGENE

Sequence:

show sequence

ACTGCCCTCGCTTCCTGTGCGTCCTCAGGTCACCGCTTGCTCTAGTTCCCAGGCTTTGGCCTCC
AGTGGACGAGAATCGCGGAGCCTGCGGGGCTGGAGGTTGAGCGCCCGGGCCAGCACCTAGGCGGGCGCGGGGGTGTGCAGGCCAGGGTTCGCGCGGGCCGGGTGGAGGCTTGAGCGGGGACCCCCGAG
CTTGAGCCCCGGAGCCGGCGGCGCTGGGGCCAGAGGGGCCGGACGGGAGGTGGCGGAGGTGGCGGCGGAGGCGAAGGGGCGGCGGGACGCGGGCCTGGCCCGTGTGTGTCCTGGCGGCCTGGCCCAGG
CTGCCGCTGTACGGTGAGCCCGAGGGAGGCGGATCTGGGTCCCGGGAAGGACACCCGCCTGGATTTGCCCCTTAGGCCCGGCCCGGGCCCCTCGGGAGCAGAACAACCTTAGTGAGGTGGACAGGAGG
GGACCTCGCGAGCAGACGCGCGCCAGCGACAGCAGCCCCGCCCCGGCCTCTCGGGAGCCGTGGGGCAGAGGCTGCGGAGCCCCAGAAGGGTCTACCAGCCACAGTCTCTGCACGTTTCCAAGAGCAGC
AGAAAATGAACACATTGCAGGGGCCAGTGTCATTCAAAGATGTGGCTGTGGATTTCACCCAGGAGGAGTGGCAGCAGCTGGACCCTGATGAGAAGATAACTTACAGGGATGTGATGTTGGAGAACTAT
AGCCATCTAGTTTCTGTGGGATATGATACCACCAAGCCAAACGTCATCATTAAGTTGGAGCAGGGAGAGGAGCCGTGGATAATGGGAGGTGAATTTCCATGTCAACATAGTCCAGAAGCCTGGAGAGT
TGATGACCTGATAGAGAGAATCCAAGAAAACGAAGACAAACATTCAAGGCAAGCTGCTTGTATCAATAGCAAAACCCTGACTGAAGAGAAAGAGAATACATTTAGTCAAATTTACATGGAAACAAGCC
TTGTTCCTTCAAGCATAATAGCTCATAATTGTGTCTCATGTGGAAAGAATTTAGAATCTATTTCGCAATTAATTAGTAGTGATGGAAGCTATGCTAGGACAAAACCTGATGAGTGTAATGAATGTGGG
AAAACATATCATGGAGAGAAAATGTGTGAATTTAATCAAAATGGGGATACCTATTCTCACAATGAAGAAAATATTCTTCAGAAAATTAGTATTTTGGAGAAACCCTTTGAATATAATGAATGCATGGA
AGCCTTAGACAATGAGGCTGTTTTTATTGCTCATAAGAGAGCTTACATAGGGGAGAAGCCCTATGAGTGGAATGATTCTGGACCAGACTTCATACAGATGTCAAATTTTAATGCATATCAGAGATCAC
AAATGGAAATGAAGCCCTTTGAATGCAGTGAATGTGGAAAATCCTTCTGTAAAAAGTCAAAATTCATCATCCACCAGAGGGCTCACACAGGAGAGAAACCTTATGAATGTAATGTATGTGGGAAATCC
TTCAGCCAAAAGGGAACCCTCACTGTACATCGGAGATCACACTTAGAGGAGAAGCCCTATAAATGTAATGAATGTGGGAAAACCTTTTGTCAGAAGTTACACCTCACTCAACACCTAAGAACTCATTC
AGGAGAGAAACCCTACGAATGTAGCGAATGTGGGAAAACCTTCTGCCAAAAGACACATCTCACCCTGCACCAGAGGAATCATTCAGGAGAGAGGCCCTATCCATGTAACGAATGTGGGAAATCCTTCT
CCCGCAAGTCTGCTCTCAGTGACCATCAGAGAACTCACACGGGAGAGAAGCTTTATAAATGTAATGAATGTGGGAAATCCTACTACCGAAAGTCTACTCTGATTACACATCAGAGAACACACACGGGA
GAGAAGCCCTATCAGTGTAGCGAGTGTGGGAAATTCTTTTCTCGGGTGTCATACCTCACTATACATTATAGAAGTCATTTAGAAGAGAAACCCTATGAATGTAATGAATGTGGCAAAACCTTCAATTT
AAATTCAGCCTTCATTAGACATCGGAAAGTACACACAGAAGAGAAATCCCATGAATGTAGTGAATGTGGAAAGTTCTCTCAGTTGTATCTCACCGACCATCATACAGCTCATTTAGAAGAGAAACCCT
ATGAATGTAATGAATGTGGGAAAACCTTCCTTGTAAATTCAGCCTTCGATGGGCACCAGCCACTTCCAAAAGGGGAGAAATCCTATGAATGTAATGTATGTGGAAAGTTATTCAATGAGTTGTCATAC
TATACTGAACATTATAGAAGTCATTCAGAAGAGAAACCTTATGGATGTAGCGAATGTGGGAAAACCTTTTCCCATAATTCATCCCTCTTCAGACATCAAAGAGTACACACAGGCGAGAAACCCTATGA
ATGTTACGAATGTGGAAAATTCTTCTCTCAGAAATCATATCTCACTATACATCATCGAATTCATTCAGGAGAGAAACCCTATGAATGTAGTAAATGTGGAAAAGTCTTCTCTCGGATGTCAAACCTCA
CTGTCCACTACAGAAGCCATTCAGGAGAGAAACCCTATGAATGTAATGAATGTGGGAAAGTCTTTTCTCAGAAGTCATACCTCACTGTACACTATAGAACTCATTCAGGAGAGAAACCCTATGAATGT
AACGAGTGTGGGAAAAAATTCCACCACAGATCAGCCTTCAATAGCCATCAGAGAATTCATAGAAGAGGAAATATGAACGTACTTGATGTGGAAAATCTCTGAAGTCAGATCTCAATTTTTAGAAAACT
CTCTGAATATAATGAATATGGGGAATCCAATAGGAAGTCAAAGCGTTTATCTGAGAGTTCGTGTTCCTGAACGGTGAGAAGCATTTAGGCATTAGAGTCATTTTAATCCAAATTTTCACAGAGAAGAA
TCCCGAAGAATGTAACAAGAAGCAAAGCCTTCAGCAAGATCATACGACTCATCGGACACTAATTTATATAGGAGTGAAGTTTTATAAATATTTAATATTTATTTTGGATTCAAATTGTATTTACATAT
CAGGGAATCATACAAAGGCAAAATCTGTCAATATGGTGAATGTGGAAAATATATTGTCTTGGAAATTTGTTGTAAAAGCCATATTTCTAATGGAAAATCAGGTGTTTACAGGAAAGATCTCAGAGGCT
ATGAGCTCTGAATAAATCTTCATTGTATAAAATGAAGTTTTTAAATTGTCAGGAGTTGATCATGAGGACAGTAGCATTAAATAAGTATATGGCCGTTTTTTATCATGTCTTAAAAATGCAATCTAATG
GTAATTCTATGCAAGTTTGGAATTGGATGACTTGTGAAGAGGCAGTTTTCTTATTTGAGTATTAGGATGGCAAAATGTATTAAGACAGGACATATTGTTGGTGAGATAATATTTAATAGGTATAAAAT
GGTAAAATACCTAGTTTTCTATTTAGAGGAATTTACAAATGGGTTTTTAACAAATGCCTCATTAGTACAGGAGGCAGTCGTTTTGTAAAGTTTTCAACTGCATCTGAGTAAGATAAGATTTTCTAAAA
GACTATTTTGATAAACTATACATACATAATTTGGAATTGTTTAAGTCTATTTCAGTGAAAGAGAACAAGCATACTGCCCATACTCTAAAATATCCCCAGCTCTCACACCACCCTTGTTTTTTAACCCA
TAGGTTTGAGTGTGCCTAGTGCCAATATTTTGTAATTTAGAAATTTTATTCACAAACTTCTGTTTGGTACAAATACAGTGTCATTGTTTTGTGCATTCTCCTTTTTCCCAGTATTTCAGAACAAATTG
ATTCAAGTTTCTAGCAGATATTTTTTGATCAATTAACTTAATGTCCTCGCTCCATTTCTTGCTGGAACAGTTTAGGTACCTACCACTTCTTCACATGACACAGGGGAATCCTGATTAGTCAAAATAAT
AATGATTTCATTCTCTTTGCCAGTAACTTGTTTTATAGTGGTCATATGACCTGATACTGGGTAAACAAAACAAAGATGGACTTGTTCTGGGAAAAGGTAAAATGGTAATCAAATAGATTGTGTTCCAG
GAATGCAAAGGTGGCTTAATATTCACAAGTCAGTTGCTATTATACACCACCTGTAGAAAAGTAATCTGGCATGCAGAACATTCTTGTGGTACAATTAATGTTCGTTTATGATCTTAGCAAATGATGGA
TTGAAAGGGACTTACTTAACTGCATAAAGAGACTTAAACTACAACAAACAATATGCTTAATGATGAAATAGTGAACATTTCTCCTAAGATTATAAAAATAAGACAAGGATATCTGCTGTCAATGATTT
TATTCGGCATTGTTCAGAAGGACCTAACCAGAAAACTAATGCAAGGAAGAGAAACAAAAGGCATAGAGATTAGAAAAGAAGTAAAACTTTAAAAACGAAAAAGAATATAAATCTCTATTTGCAGATGC
CATGAGTAAATTTGGTAAGTTCCCTGCATAAAAGTTATGCAAAAAGCATTTTATGATATACCAGCAAAAAACATGGAAAATGAAATTTTGAAAAGCAATGCCACTTCAAAGATCCCTCAAGTGCCTAG
AGGGAGAAAATGAGTTAATATGCTTTGAAGAACTGTATCCAGAAAATAAAATTACAAAGGAGGAGAGGGATAGGATTCCAGGACAATCTCAAAACTATTGCTTTTTCCTAAATTCATTGCAACCTTAA
AATCCTAGCAAGTTCTTTAATGTAAATTAACAAGCTAATTCTAGAATTCATATGCATATTCAAAAGTCGAATAATTGTCAAGGCTATCCTGTAGAATGGACAGAGAGGATTGAAATTTCTAAATATCA
AGACCTGTTATAAAGCCATAGAAATAATGAAGGTGTTAATTTGGCACAAGGATGAAAAAACTGACTAGTGGAACAGCATACAGATTCAAAAGTAGACCCACGTGTATACCATCACCTGAGTTTTGAGA
AAGGTGACATTGAAGTGTAGTGGGGGAAAGGGTGTTCTTTCCAGTAAATGTACTTTGCCAATAAAATTTTGTAATTTGATAAAAAGTTATTTGGAGGTGGATTGCAGATCTGAATATGAAATGTGAAA
GCTTTACAAAGAAATCTTAGGACAGTTTGTAATCTTGGAGTAAGCAAAGGTTTATTGAGACCCAAAAAGCATTAACCCATAAAATTAGAACTTAATATTAAATTTGAGAACTTCTATTTATCAGAAAG
ACCACCAGTAAGAAAATGAACAGGAAATCATGGGGAGGAGAAGATATTTGCAGTTCATGTATGTGACAACAGCACCGAGTATAGCAGAAGTGTTGGCAAACTTTATAAAGCAAGGCACCAGATGGTGA
AAATTTTCAGCTTTGTCACAACTGCTCATCTTTGCTATTGTGTGAAAGCATCCATACACCATGCATTAAAAAAAAAATGAGCATGGCTGCTTCCCAGTAAAACCATTCACAATCCCAGGTGGCAGTCT
GGATTTGGTCTGCACTCATAGTTTTCTGGTCCCTGATCTCGAATATGTAAAGAGCACCTACAAATCAACAAGGGGGAAACTGGAAAAGGCAAAAGACTTTAGAGGATATCCACTCACTTTAGAGGATA
TCCAGACGGCCAATAAGCATGAAAAGATGTGTTAGCTTTATTAGTAATCAGGGAAATGCAAACTTAAAACATGTAGCACTGCTACCCATCCATGGAAATGGTTAAAATGAAAAGCATGAAAAAGCATC
ACGTTTTGGCAAGGATGTAAGCAAGAGGAACTGTACACTACTGGTGGAATTGCTCATCGATAAAACCATTTTGAAAGCTGGCACTAAAAGCCAAGCATATGTATACTGTTTTACCCAAACCCAGCAAA
AATGCATGTGTCTGTCCACCAAAGGACATGCACTAGAATATTTATAGCCTAAAACTGCACAAAACAGAACTATCTTAAGGCACATGTGCAATGGAATGAATAAAGAAGTGGCATATGTCCATGGAATA
CTGTAAAACAGTGAGCATGAATGAACTAGAAGTCCGTGTAATAACGCAGCTGAATTTAACAAACCTTGCTGAATGAAAGACTCCAGACACAAAAGCCAACATGCTGTATGATTCCTTCTATATAAATT
ATAAAGACGGGCAAAACTTGTATACGTGGTTTAAAATTAGGGTAGCAGTTAGCCTTGGCCAAGGCTGAAAGGGGGCATTTATCTGGTGCTGGGAATAATCTGTTTCTAAACCTAGGTGCTAAGTATTT
GAGTGTGTTTTGAGCTGTGCACTTAAGATATGTGTATTTTTCTGCATGTGTGTTAAACTTTCCATAAAAGTTTTCTAAAATCACAAATGGCTAACATTTGTGTCGCTCATCACTCTAATCATATTTTT
CTAGATGTGTATGAATATGCTGCACAACAGGAATTAAATGGCAGATTTTGCATAATTCTGTGCAGGAAATACATATTTATAGTAATTTTGATGGCAACTACTAAGATTTCCTACGCTGTCCTTAAAGC
TTAGCATAATGTATATTTTAAGTGAAATATTTGAGAAGGTTAAAGAATCATTACATACTTTGTCATCCTATACTTTTGCATATATAAATAGGTCTGAGCTGCCTCTTCAATAAAGAAGCTAATGTGTA
ACATTTCATATTTCCCTAAA

hide sequence


Protein RefSeqs	NP_001191385	(Get FASTA)	NCBI Sequence Viewer
	NP_066986	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAI36676	(Get FASTA)	NCBI Sequence Viewer
	AAI36677	(Get FASTA)	NCBI Sequence Viewer
	AAQ93364	(Get FASTA)	NCBI Sequence Viewer
	BAF85758	(Get FASTA)	NCBI Sequence Viewer
	CCQ43665	(Get FASTA)	NCBI Sequence Viewer
	EAW87321	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000275423
	ENSP00000275423.4
	ENSP00000380120
	ENSP00000380120.1
GenBank Protein	Q9NYW8	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:

NP_066986 ⟸ NM_021163

- UniProtKB:

B9EGS1 (UniProtKB/Swiss-Prot), B2RN44 (UniProtKB/Swiss-Prot), A8KAK4 (UniProtKB/Swiss-Prot), A6NDF2 (UniProtKB/Swiss-Prot), F8W6M7 (UniProtKB/Swiss-Prot), Q9NYW8 (UniProtKB/Swiss-Prot)

- Sequence:

show sequence

MNTLQGPVSFKDVAVDFTQEEWQQLDPDEKITYRDVMLENYSHLVSVGYDTTKPNVIIKLEQGEEPWIMGGEFPCQHSPEAWRVDDLIERIQENEDKHSRQAACINSKTLTEEKENTFSQIYMETSLV
PSSIIAHNCVSCGKNLESISQLISSDGSYARTKPDECNECGKTYHGEKMCEFNQNGDTYSHNEENILQKISILEKPFEYNECMEALDNEAVFIAHKRAYIGEKPYEWNDSGPDFIQMSNFNAYQRSQM
EMKPFECSECGKSFCKKSKFIIHQRAHTGEKPYECNVCGKSFSQKGTLTVHRRSHLEEKPYKCNECGKTFCQKLHLTQHLRTHSGEKPYECSECGKTFCQKTHLTLHQRNHSGERPYPCNECGKSFSR
KSALSDHQRTHTGEKLYKCNECGKSYYRKSTLITHQRTHTGEKPYQCSECGKFFSRVSYLTIHYRSHLEEKPYECNECGKTFNLNSAFIRHRKVHTEEKSHECSECGKFSQLYLTDHHTAHLEEKPYE
CNECGKTFLVNSAFDGHQPLPKGEKSYECNVCGKLFNELSYYTEHYRSHSEEKPYGCSECGKTFSHNSSLFRHQRVHTGEKPYECYECGKFFSQKSYLTIHHRIHSGEKPYECSKCGKVFSRMSNLTV
HYRSHSGEKPYECNECGKVFSQKSYLTVHYRTHSGEKPYECNECGKKFHHRSAFNSHQRIHRRGNMNVLDVENL

hide sequence

RefSeq Acc Id:

NP_001191385 ⟸ NM_001204456

- UniProtKB:

B9EGS1 (UniProtKB/Swiss-Prot), B2RN44 (UniProtKB/Swiss-Prot), A8KAK4 (UniProtKB/Swiss-Prot), A6NDF2 (UniProtKB/Swiss-Prot), F8W6M7 (UniProtKB/Swiss-Prot), Q9NYW8 (UniProtKB/Swiss-Prot)

- Sequence:

show sequence

MNTLQGPVSFKDVAVDFTQEEWQQLDPDEKITYRDVMLENYSHLVSVGYDTTKPNVIIKLEQGEEPWIMGGEFPCQHSPEAWRVDDLIERIQENEDKHSRQAACINSKTLTEEKENTFSQIYMETSLV
PSSIIAHNCVSCGKNLESISQLISSDGSYARTKPDECNECGKTYHGEKMCEFNQNGDTYSHNEENILQKISILEKPFEYNECMEALDNEAVFIAHKRAYIGEKPYEWNDSGPDFIQMSNFNAYQRSQM
EMKPFECSECGKSFCKKSKFIIHQRAHTGEKPYECNVCGKSFSQKGTLTVHRRSHLEEKPYKCNECGKTFCQKLHLTQHLRTHSGEKPYECSECGKTFCQKTHLTLHQRNHSGERPYPCNECGKSFSR
KSALSDHQRTHTGEKLYKCNECGKSYYRKSTLITHQRTHTGEKPYQCSECGKFFSRVSYLTIHYRSHLEEKPYECNECGKTFNLNSAFIRHRKVHTEEKSHECSECGKFSQLYLTDHHTAHLEEKPYE
CNECGKTFLVNSAFDGHQPLPKGEKSYECNVCGKLFNELSYYTEHYRSHSEEKPYGCSECGKTFSHNSSLFRHQRVHTGEKPYECYECGKFFSQKSYLTIHHRIHSGEKPYECSKCGKVFSRMSNLTV
HYRSHSGEKPYECNECGKVFSQKSYLTVHYRTHSGEKPYECNECGKKFHHRSAFNSHQRIHRRGNMNVLDVENL

hide sequence

Ensembl Acc Id:

ENSP00000275423 ⟸ ENST00000353796

Ensembl Acc Id:

ENSP00000380120 ⟸ ENST00000396912

Protein Domains

KRAB

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-Q9NYW8-F1-model_v2	AlphaFold	Q9NYW8	1-714	view protein structure

RGD ID:

7209851

Promoter ID:

EPDNEW_H10672

Type:

initiation region

Name:

RBAK_1

Description:

RB associated KRAB zinc finger

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H10670 EPDNEW_H10671 EPDNEW_H10673

Experiment Methods:

Single-end sequencing.; Paired-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	7	5,045,860 - 5,045,920	EPDNEW

RGD ID:

6805547

Promoter ID:

HG_KWN:56127

Type:

CpG-Island

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

CD4+TCell, CD4+TCell_12Hour, HeLa_S3, K562, Lymphoblastoid, NB4

Transcripts:

ENST00000396904, NM_021163, UC010KSS.1

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	7	5,051,786 - 5,052,286 (+)	MPROMDB

RGD ID:

7209855

Promoter ID:

EPDNEW_H10673

Type:

multiple initiation site

Name:

RBAK_3

Description:

RB associated KRAB zinc finger

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H10670 EPDNEW_H10672 EPDNEW_H10671

Experiment Methods:

Single-end sequencing.; Paired-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	7	5,067,829 - 5,067,889	EPDNEW

Database	Acc Id	Source(s)
COSMIC	RBAK	COSMIC
Ensembl Genes	ENSG00000146587	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000353796	ENTREZGENE
	ENST00000353796.7	UniProtKB/Swiss-Prot
	ENST00000396912	ENTREZGENE
	ENST00000396912.2	UniProtKB/Swiss-Prot
Gene3D-CATH	6.10.140.140	UniProtKB/Swiss-Prot
	Classic Zinc Finger	UniProtKB/Swiss-Prot
GTEx	ENSG00000146587	GTEx
HGNC ID	HGNC:17680	ENTREZGENE
Human Proteome Map	RBAK	Human Proteome Map
InterPro	KRAB	UniProtKB/Swiss-Prot
	KRAB_dom_sf	UniProtKB/Swiss-Prot
	Znf_C2H2_sf	UniProtKB/Swiss-Prot
	Znf_C2H2_type	UniProtKB/Swiss-Prot
KEGG Report	hsa:57786	UniProtKB/Swiss-Prot
NCBI Gene	57786	ENTREZGENE
OMIM	608191	OMIM
PANTHER	C2H2-TYPE DOMAIN-CONTAINING PROTEIN	UniProtKB/Swiss-Prot
	ZINC FINGER AND SCAN DOMAIN-CONTAINING	UniProtKB/Swiss-Prot
Pfam	KRAB	UniProtKB/Swiss-Prot
	zf-C2H2	UniProtKB/Swiss-Prot
PharmGKB	PA162400745	PharmGKB
PROSITE	KRAB	UniProtKB/Swiss-Prot
	ZINC_FINGER_C2H2_1	UniProtKB/Swiss-Prot
	ZINC_FINGER_C2H2_2	UniProtKB/Swiss-Prot
SMART	KRAB	UniProtKB/Swiss-Prot
	ZnF_C2H2	UniProtKB/Swiss-Prot
Superfamily-SCOP	SSF109640	UniProtKB/Swiss-Prot
	SSF57667	UniProtKB/Swiss-Prot
UniProt	A6NDF2	ENTREZGENE
	A8KAK4	ENTREZGENE
	B2RN44	ENTREZGENE
	B9EGS1	ENTREZGENE
	F8W6M7	ENTREZGENE
	L8E8N4_HUMAN	UniProtKB/TrEMBL
	Q9NYW8	ENTREZGENE, UniProtKB/Swiss-Prot
UniProt Secondary	A6NDF2	UniProtKB/Swiss-Prot
	A8KAK4	UniProtKB/Swiss-Prot
	B2RN44	UniProtKB/Swiss-Prot
	B9EGS1	UniProtKB/Swiss-Prot
	F8W6M7	UniProtKB/Swiss-Prot

Nomenclature History

Date	Current Symbol	Current Name	Previous Symbol	Previous Name	Description	Reference	Status
2016-02-16	RBAK	RB associated KRAB zinc finger		RB-associated KRAB zinc finger	Symbol and/or name change	5135510	APPROVED

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Imported Disease Annotations - ClinVar

Imported Human Phenotype Annotations - ClinVar

Send us a Message

Imported Disease Annotations - ClinVar

Imported Human Phenotype Annotations - ClinVar